1 / 26

Electronic Consumer Health Information: Where Has It Been? Where Is It Going?

Electronic Consumer Health Information: Where Has It Been? Where Is It Going?. Jacquelyn Burkell Grant Campbell Faculty of Information and Media Studies University of Western Ontario OLA Super Conference 2004. Outline of Presentation:. Consumer Health Decisions Screening Tests

meir
Download Presentation

Electronic Consumer Health Information: Where Has It Been? Where Is It Going?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Electronic Consumer Health Information:Where Has It Been?Where Is It Going? Jacquelyn Burkell Grant Campbell Faculty of Information and Media Studies University of Western Ontario OLA Super Conference 2004

  2. Outline of Presentation: • Consumer Health Decisions • Screening Tests • The Sensitivity / Specificity Paradox • Allowing for the Decision • Electronic Consumer Health Information • Previous and Current Consumer Health Information • The Use of Metadata to Retrieve Documents • The Use of Metadata to Retrieve Information • Where We’re Headed

  3. Sensitivity The percentage of real cases that test positive Sensitivity = True Positives True Positives + False Negatives

  4. Specificity The percentage of negative cases that test negative Specificity = True Negatives True Negatives + False Positives

  5. Base Rate • Incidence of the condition in the population being tested.

  6. Example: The Maternal Serum Screening Test for Down’s Syndrome Base rate: 1% Sensitivity of test: 90% Specificity of test: 60%

  7. Presence or Absence of Condition Test Result

  8. Base Rate = 1% Incidence = 10 / 1000 Presence or Absence of Condition Test Result

  9. Sensitivity = 90 % Presence or Absence of Condition Test Result

  10. Specificity = 60% Presence or Absence of Condition Test Result

  11. In any given 1,000 tests: 595 are likely to test negative, of which 1 will be a false negative. 405 are likely to test positive, of which 396 will be false positives. Presence or Absence of Condition Test Result

  12. Positive Predictive Value: Negative Predictive Value: 9/405 = 2.2 % 594/595 = 99.8 % Predictive Values:

  13. Positive Predictive Value: 0.25%

  14. Positive Predictive Value: 0.48%

  15. Positive Predictive Value: 2.2%

  16. Positive Predictive Value: 6.7%

  17. The State of Things In the Past • The “Vertical File” • Collections of articles, pamphlets and other ephemeral information sources, generally written for the lay person, containing practical advice on a variety of consumer health issues.

  18. The State of Things In the Present • The “Web Resource Guide” • Subject-oriented electronic pathfinders, providing organized access to Web resources on consumer health issues • Example

  19. Improvements: Stage One • Database Searching Assistance • The design of preformulated queries of medical databases based on anticipated decision-making needs • Example

  20. Improvements: Stage Two • Metadata to Retrieve Web Documents • The use of a standard metadata element set to facilitate the retrieval of Web-based objects • The Dublin Core • Expansions

  21. Improvements: Stage Three • Metadata to Retrieve Data Elements Within Documents • The use of metadata elements to mark parts of documents for subsequent retrieval and assembly into new documents • Automatic indexing or Manual indexing • Controlled vocabulary searching (MeSH)

  22. MeSH: Psychological Phenomena --Mental Processes --Thinking --Decision Making MeSH: Investigative Techniques --Epidemiological Methods --Statistics --Sensitivity and Specificity MeSH: Diagnostic Imaging --Radiography --Mammography

  23. What do we need to watch for in this brave new world? • Where can the information that people need be found? • Are the knowledge structures that we use sufficiently flexible for consumer health? • Is the information being presented in a way that promotes comprehension, and minimizes the risk of misinformation?

  24. Please contact us for further information! Jacquelyn Burkell (jburkell@uwo.ca) Grant Campbell (gcampbel@uwo.ca) Faculty of Information and Media Studies University of Western Ontario London, Ontario N6A 5B7

More Related